Matthew Sheerin
Stock Analyst at Needham
(3.87)
# 646
Out of 5,149 analysts
156
Total ratings
69.41%
Success rate
31.51%
Average return
Main Sectors:
Stocks Rated by Matthew Sheerin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 | $23.77 | +26.21% | 2 | Apr 10, 2025 | |
| CLS Celestica | Maintains: Buy | $140 → $150 | $256.95 | -41.62% | 13 | Feb 19, 2025 | |
| EVH Evolent Health | Initiates: Buy | $15 | $3.51 | +327.35% | 1 | Jan 10, 2025 | |
| AGL agilon health | Reiterates: Hold | n/a | $0.57 | - | 1 | Jan 10, 2025 | |
| JBL Jabil | Reiterates: Buy | $150 → $160 | $254.24 | -37.07% | 14 | Dec 19, 2024 | |
| PLXS Plexus | Maintains: Hold | $136 → $150 | $193.91 | -22.64% | 2 | Dec 10, 2024 | |
| FLEX Flex Ltd. | Maintains: Buy | $40 → $48 | $63.08 | -23.91% | 8 | Dec 10, 2024 | |
| HPE Hewlett Packard Enterprise Company | Maintains: Buy | $22 → $25 | $21.64 | +15.53% | 4 | Dec 6, 2024 | |
| PSTG Everpure | Maintains: Hold | $60 → $65 | $61.74 | +5.28% | 13 | Dec 4, 2024 | |
| NTAP NetApp | Maintains: Buy | $140 → $145 | $98.79 | +46.78% | 15 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $24.41 | +14.71% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $43 → $38 | $35.30 | +7.65% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $280 | $344.50 | -18.72% | 8 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $2.5 | $2.27 | +10.13% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $50 → $55 | $63.77 | -13.75% | 10 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $104.05 | -76.93% | 3 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $260 | $125.28 | +107.54% | 6 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.53 | +3,322.05% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $112 → $66 | $129.58 | -49.07% | 8 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $90 | $79.83 | +12.74% | 7 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.95 | +39.28% | 7 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $145 | $204.31 | -29.03% | 2 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $120 | $156.17 | -23.16% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $315 | $497.42 | -36.67% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $150 | $86.22 | +73.97% | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $130 → $105 | $145.85 | -28.01% | 11 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $20 | $14.75 | +35.59% | 1 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $20 | $0.71 | +2,664.39% | 2 | Nov 27, 2019 |
Privia Health Group
Apr 10, 2025
Reiterates: Buy
Price Target: $30
Current: $23.77
Upside: +26.21%
Celestica
Feb 19, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $256.95
Upside: -41.62%
Evolent Health
Jan 10, 2025
Initiates: Buy
Price Target: $15
Current: $3.51
Upside: +327.35%
agilon health
Jan 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.57
Upside: -
Jabil
Dec 19, 2024
Reiterates: Buy
Price Target: $150 → $160
Current: $254.24
Upside: -37.07%
Plexus
Dec 10, 2024
Maintains: Hold
Price Target: $136 → $150
Current: $193.91
Upside: -22.64%
Flex Ltd.
Dec 10, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $63.08
Upside: -23.91%
Hewlett Packard Enterprise Company
Dec 6, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.64
Upside: +15.53%
Everpure
Dec 4, 2024
Maintains: Hold
Price Target: $60 → $65
Current: $61.74
Upside: +5.28%
NetApp
Nov 22, 2024
Maintains: Buy
Price Target: $140 → $145
Current: $98.79
Upside: +46.78%
Nov 18, 2024
Initiates: Buy
Price Target: $28
Current: $24.41
Upside: +14.71%
Nov 5, 2024
Maintains: Hold
Price Target: $43 → $38
Current: $35.30
Upside: +7.65%
Aug 13, 2024
Upgrades: Buy
Price Target: $270 → $280
Current: $344.50
Upside: -18.72%
Aug 9, 2024
Maintains: Buy
Price Target: $3 → $2.5
Current: $2.27
Upside: +10.13%
Aug 9, 2024
Maintains: Hold
Price Target: $50 → $55
Current: $63.77
Upside: -13.75%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $24
Current: $104.05
Upside: -76.93%
Jul 17, 2024
Maintains: Buy
Price Target: $250 → $260
Current: $125.28
Upside: +107.54%
Jul 1, 2024
Initiates: Buy
Price Target: $18
Current: $0.53
Upside: +3,322.05%
Jun 13, 2024
Maintains: Hold
Price Target: $112 → $66
Current: $129.58
Upside: -49.07%
May 23, 2024
Maintains: Hold
Price Target: $80 → $90
Current: $79.83
Upside: +12.74%
Apr 3, 2024
Reiterates: Buy
Price Target: $25
Current: $17.95
Upside: +39.28%
Jan 25, 2024
Maintains: Hold
Price Target: $140 → $145
Current: $204.31
Upside: -29.03%
Sep 19, 2023
Maintains: Buy
Price Target: $110 → $120
Current: $156.17
Upside: -23.16%
Apr 19, 2023
Maintains: Buy
Price Target: $285 → $315
Current: $497.42
Upside: -36.67%
Apr 12, 2023
Downgrades: Hold
Price Target: $150
Current: $86.22
Upside: +73.97%
Oct 10, 2022
Maintains: Hold
Price Target: $130 → $105
Current: $145.85
Upside: -28.01%
Aug 11, 2022
Maintains: Hold
Price Target: $24 → $20
Current: $14.75
Upside: +35.59%
Nov 27, 2019
Maintains: Hold
Price Target: $15 → $20
Current: $0.71
Upside: +2,664.39%